Company Overview and News

 
Cut the Red Tape So Middle-Class Investors Can Soar With Next Amazon – ValueWalk Premium

14h valuewalkpremium
Today is the 21st anniversary of the initial public offering of a little company called Amazon. Yes, today Amazon is a behemoth, a supposed unbreakable monopoly, but back in 2000, it faced an uncertain future as an online startup going head-to-head with the “big boys” of Borders and Barnes & Noble.

 
Equilibrium Valuation Model: A Regression-Based Fundamental Equity Valuation Model

20h seekingalpha
This article proposes a systematic regression-based fundamental equity valuation model that can potentially be applied in areas such as quantitative finance and machine learning.

 
Cisco Systems: The Market Expected Too Much

21h seekingalpha
The net cash position is down to only $26.3 billion not including a large tax liability.

 
Has Cisco Systems (CSCO) Outpaced Other Computer and Technology Stocks This Year?

22h zacks
Investors focused on the Computer and Technology space have likely heard of Cisco Systems (CSCO - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Computer and Technology peers, we might be able to answer that question.

 
Cisco Systems: Should We Be Worried?

2018-05-21 seekingalpha
Prior to the earnings release, CSCO had gained 32% in a year but markets have not responded well in the last few trading sessions.

 
Boeing Returns as Top Performing Dow Stock

2018-05-19 247wallst
Boeing Co. (NYSE: BA) regained its place last week as the top-performing Dow Jones industrial stock for the year to date. The company’s shares added nearly 2.6% during the week to muster a 19.1% gain since the beginning of the year.

 
Weak Guidance and Poor Services Revenue Growth Pulled Cisco Down

2018-05-18 marketrealist
Cisco Systems (CSCO) reported its fiscal third-quarter1 numbers on May 16. While the company beat earnings and revenue estimates, tepid guidance led its stock to fall 4.3% in after-hours trading on Wednesday.

 
Dow 30 Stock Roundup: Walmart, Cisco, Home Depot Beat on Earnings

2018-05-18 zacks
The Dow snapped a record streak of wins to traverse a turbulent week. Trade-war related concerns continued to weigh on investors with President Trump expressing doubts over the success of upcoming negotiations with China. Additionally, the spike in 10-year Treasury yield also spooked markets, sparking off fresh inflationary concerns. Such fears were also stoked by encouraging retail sales numbers.

 
Stock Market News For May 18, 2018

2018-05-18 zacks
U.S. stock markets ended lower on Thursday after President Donald Trump expressed doubts about the possibility of successful trade negotiations with China. All three major indexes closed in the negative territory. Moreover, rising yields on the U.S. government bonds and geopolitical tensions weighed on investors to such an extent that a strong showing by the energy sector failed to stop a slide in stock prices.

 
Tencent: Confounding The Doubters

2018-05-18 seekingalpha
Tencent announced its Q1 2018 results which handily surpassed market expectations for both revenue and earnings.

 
Wall Street ends slightly lower on trade, oil price concerns

2018-05-18 thehindubusinessline
The Dow Jones Industrial Average fell 54.95 points, or 0.22 per cent, to 24,713.98, the S&P 500 lost 2.33 points, or 0.09 per cent, to 2,720.13 and the Nasdaq Composite dropped 15.82 points, or 0.21 per cent, to 7,382.47.

 
Wall Street ends down slightly on trade, oil price concerns

2018-05-18 moneycontrol
Wall Street ended a choppy trading session lower on Thursday, as investors grappled with escalating trade tensions and rising oil prices.

 
U.S. Stocks Slip as Dollar Rises, Treasuries Fall: Markets Wrap - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Russian oligarch Viktor Vekselberg chairs nonprofit backed by US firms, politicians

2018-05-17 cnbc
Viktor Vekselberg, the Russian oligarch at the center of a widening scandal over influence peddling by President Donald Trump's lawyer Michael Cohen, has been banned from doing business in America under U.S. sanctions. But as of this week, Vekselberg was still the chairman of a U.S. nonprofit group that boasts support from several Fortune 100 corporations and one of Trump's top advisors.

 
Kroger and Williams Partners jump while Cisco Systems sinks

2018-05-17 nzherald.co.nz
The seller of switches, routers and software's results met expectations, but analysts worried about its profit margins and other issues.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

19h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 17275R102